Terumo Company Description
Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally.
The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.
The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular and stent grafts.
The Medical Care Solutions Company segment provides syringes, infusion pumps, syringe pumps, infusion lines, I.V.
solutions, peritoneal dialysis fluids, pain management and nutritious food products, adhesion barriers, and others; blood glucose monitoring systems, disposable needles for pen-injector, insulin patch pumps, blood pressure monitors, digital thermometers, and others; and contract manufacturing of prefilled syringes, devices to pharmaceutical companies for use in drug kits, such as prefillable syringes, needles for pharmaceutical packaging business, and others.
The Blood and Cell Technologies Company segment offers blood bags, component collection systems, automated blood processing systems, pathogen reduction systems, centrifugal apheresis systems, cell expansion systems, and others.
The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974.
Terumo Corporation was incorporated in 1921 and is headquartered in Tokyo, Japan.
| Country | Japan |
| Founded | 1921 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 30,591 |
| CEO | Hikaru Samejima |
Contact Details
Address: 2-44-1, Hatagaya Tokyo, 151-0072 Japan | |
| Phone | 81 3 3374 8111 |
| Website | terumo.com |
Stock Details
| Ticker Symbol | TRUMY |
| Exchange | OTCMKTS |
| Fiscal Year | April - March |
| Reporting Currency | JPY |
| ISIN Number | US88156J1051 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Hikaru Samejima | Representative Director, President and Chief Executive Officer |
| Toshiaki Takagi | Chairman of the Board and Group Managing Executive Officer |
| Jin Hagimoto | Chief Financial Officer, CIO, GM of CFO Office, Controller and Treasury Tax Dept., J-SOX Office, IT Planning Dept. & GBS |
| Shinji Omori | Chief Technology Officer, GM of DX Promotion Dept. Research & Development Division and Executive Officer |
| Miho Mizuguchi | Executive Officer, Chief Legal Officer and GM of CLO Office, Legal and Compliance Department |
| Tomoko Adachi | Chief Human Resources Officer and Group Executive Officer |
| Kazunori Hirose | Director and Group Managing Executive Officer |
| Itaru Sakaguchi | Group Managing Executive Officer |
| Toshihiko Osada | Group Senior Managing Executive Officer and Director |
| Fumihisa Hirose | Group Managing Executive Officer |